Latest Share Chat

REMOVE ADS

CATCo Regulatory News (CAT)

CATCo Information

This share is currently suspended. It was suspended at a price of 37.50

There is currently no data for CAT

REMOVE ADS

Directors Dealing

16 Dec 2011 16:06

RNS Number : 1779U

CATCo Reinsurance Opps Fund Ltd

16 December 2011

CATCo Reinsurance Opportunities Fund Ltd.

Directors Dealing

To: SFM, London Stock Exchange and Bermuda Stock Exchange 16 December 2011

CATCo Reinsurance Opportunities Fund Ltd (the "Company") was informed today that, on 16 December 2011, James Keyes acquired 47,528 C-shares (CATC.L) at a price of $$1.052 per C-Share.

Following this purchase, Mr Keyes has an interest of 47,528 shares, representing 0.0014 per cent. of the issued share capital of the Company.

For further information, please contact:

Jason Bibb

CATCo Investment Management Ltd

Telephone: +1 441 531 2227

Email: jason.bibb@catcoim.com

Mark Way

CATCo Investment Management Ltd

Telephone: +44 7786 116991

Email: mark.way@catcoim.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGMMMZVVKGMZM

Date		Source	Headline
13th Jun 2006	4:50 pm	RNS	Rule 8.3- Cambridge Antibody
13th Jun 2006	3:54 pm	RNS	Rule 2.10 Announcement
13th Jun 2006	12:18 pm	RNS	EPT Disclosure
13th Jun 2006	11:42 am	RNS	EPT Disclosure
13th Jun 2006	11:35 am	RNS	EPT Disclosure
13th Jun 2006	10:20 am	RNS	EPT Disclosure
12th Jun 2006	5:35 pm	RNS	Rule 8.3 - Cambridge Antibody
12th Jun 2006	12:00 pm	RNS	EPT Disclosure
12th Jun 2006	11:34 am	RNS	EPT Disclosure
12th Jun 2006	11:14 am	RNS	Rule 8.3- (CAT)
12th Jun 2006	10:08 am	RNS	EPT Disclosure
12th Jun 2006	7:00 am	RNS	Rule 8.3- Cambridge Antibody
9th Jun 2006	1:30 pm	RNS	Rule 8.3- (CAT)
9th Jun 2006	12:36 pm	RNS	EPT Disclosure
9th Jun 2006	11:56 am	RNS	EPT Disclosure
9th Jun 2006	11:54 am	RNS	EPT Disclosure
9th Jun 2006	11:38 am	RNS	Rule 8.3-Cambridge Antibody
8th Jun 2006	4:19 pm	RNS	Rule 2.10 Announcement
8th Jun 2006	2:21 pm	RNS	EPT Disclosure
8th Jun 2006	1:14 pm	RNS	Rule 8.3- (CAT)
8th Jun 2006	10:49 am	RNS	EPT Disclosure
7th Jun 2006	5:01 pm	RNS	Holding(s) in Company
7th Jun 2006	4:55 pm	RNS	Rule 8.3- Cambridge Anti Tech
7th Jun 2006	12:38 pm	RNS	Rule 8.3- (CAT)
7th Jun 2006	12:08 pm	RNS	EPT Disclosure
7th Jun 2006	10:00 am	RNS	Offer for Cambridge Antibody
6th Jun 2006	4:01 pm	RNS	Rule 8.3- Cambridge Antibody
6th Jun 2006	3:45 pm	RNS	Rule 8.3- Cambridge Antibody
6th Jun 2006	12:43 pm	RNS	EPT Disclosure
5th Jun 2006	6:00 pm	RNS	EPT Disclosure
5th Jun 2006	1:10 pm	RNS	Rule 8.3- (CAT)
5th Jun 2006	12:55 pm	RNS	EPT Disclosure
5th Jun 2006	11:24 am	RNS	EPT Disclosure
2nd Jun 2006	2:14 pm	RNS	EPT Disclosure
2nd Jun 2006	1:19 pm	RNS	Rule 8.3- (CAT)
2nd Jun 2006	12:27 pm	RNS	EPT Disclosure
2nd Jun 2006	12:22 pm	RNS	EPT Disclosure
2nd Jun 2006	7:00 am	RNS	Rule 8.3- Cambridge Antibody
1st Jun 2006	4:22 pm	RNS	Rule 8.3- Cambridge Antibody
1st Jun 2006	3:21 pm	RNS	Holding(s) in Company
1st Jun 2006	12:25 pm	RNS	EPT Disclosure
1st Jun 2006	11:10 am	RNS	EPT Disclosure
31st May 2006	3:13 pm	RNS	Rule 8.3- (CAT)
31st May 2006	3:00 pm	RNS	Merger Update
31st May 2006	1:04 pm	RNS	Rule 8.3- Cambridge Antibody
31st May 2006	11:43 am	RNS	EPT Disclosure
31st May 2006	11:27 am	RNS	EPT Disclosure
31st May 2006	11:25 am	RNS	EPT Disclosure
30th May 2006	3:25 pm	RNS	Rule 8.3- (CAT)
30th May 2006	3:16 pm	RNS	EPT Disclosure

Latest Share Chat

CATCo Regulatory News (CAT)

Directors Dealing

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending